Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure.
Sign Up to like & getrecommendations! Published in 2021 at "ESC heart failure"
DOI: 10.1002/ehf2.13659
Abstract: AIMS We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). METHODS AND RESULTS In the first stage, 83… read more here.
Keywords: circulating serpina3; serpina3 levels; heart failure; novo worsened ... See more keywords